Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Pharmaceutical intermediates >  Heterocyclic compound >  Pyridine compound >  Pyridine derivatives >  4-CHLOROFURO[3,2-C]PYRIDINE

4-CHLOROFURO[3,2-C]PYRIDINE

Basic information Safety Supplier Related

4-CHLOROFURO[3,2-C]PYRIDINE Basic information

Product Name:
4-CHLOROFURO[3,2-C]PYRIDINE
Synonyms:
  • SALOR-INT L299537-1EA
  • 4-CHLOROFURO[3,2-]PYRIDINE
  • 4-Chlorofuro[3,2-c]pyridine, 95+%
  • 1. 4-Chlorofuro[3,2-C]Pyridine
  • 4-CHLOROFURO[3,2-C]PYRIDINE
  • 4-Chlorofuro[3,2-c]pyridine HCl
  • 4-Chloro-5-azabenzo[b]furan, 4-Chloro-5-aza-1-benzofuran
  • 104328
CAS:
31270-80-1
MF:
C7H4ClNO
MW:
153.57
EINECS:
800-345-4
Product Categories:
  • Heterocycles series
  • Halides
  • Fused Ring Systems
Mol File:
31270-80-1.mol
More
Less

4-CHLOROFURO[3,2-C]PYRIDINE Chemical Properties

Melting point:
41 °C
Boiling point:
243℃
Density 
1.377
Flash point:
101℃
storage temp. 
under inert gas (nitrogen or Argon) at 2-8°C
form 
solid
pka
-0.69±0.30(Predicted)
color 
Orange
InChI
InChI=1S/C7H4ClNO/c8-7-5-2-4-10-6(5)1-3-9-7/h1-4H
InChIKey
OPFFYLJLHPZSEO-UHFFFAOYSA-N
SMILES
C1(Cl)=NC=CC2OC=CC1=2
More
Less

Safety Information

Hazard Codes 
Xi
Risk Statements 
36/37/38
Safety Statements 
26-36/37/39
Hazard Note 
Irritant
HS Code 
2932190090
More
Less

4-CHLOROFURO[3,2-C]PYRIDINE Usage And Synthesis

Definition

ChEBI: 4-Chlorofuro[3,2-c]pyridine is a furopyridine.

Synthesis

26956-43-4

31270-80-1

General procedure for the synthesis of 4-chlorofuranylpyridine from 4,5-dihydro-4-oxofuro[3,2]pyridine: cf. Example 4 Synthesis of 4-chlorofuro[3,2-c]pyridine. 4,5-Dihydro-4-oxofuro[3,2]pyridine (72.2 g, 534 mmol) was added to phosphorochloridic acid (100 mL) preheated to 120 °C with continuous stirring for 30 min. Upon completion of the reaction, the solvent was removed by distillation under reduced pressure. Ice-cooled water was added to the residue and the pH was adjusted to basic with 8 M aqueous sodium hydroxide, followed by extraction with ethyl acetate. The organic phases were combined, washed with saturated brine and dried over anhydrous sodium sulfate. The solvent was again removed by distillation under reduced pressure and the resulting crude product was purified by silica gel column chromatography (eluent: ethyl acetate/hexane=30/70) to afford the target product 4-chlorofuranylpyridine (66.1 g, 81% yield). The product was characterized by 1H-NMR (CDCl3): δ 7.13 (1H, dd, J = 2.2, 1.0 Hz), 7.79 (1H, dd, J = 5.8, 1.0 Hz), 8.27 (1H, d, J = 2.2 Hz), 8.32 (1H, d, J = 5.8 Hz).

References

[1] Bioorganic and Medicinal Chemistry Letters, 2007, vol. 17, # 1, p. 250 - 254
[2] Journal of Medicinal Chemistry, 1989, vol. 32, # 6, p. 1147 - 1156
[3] Patent: EP2100895, 2009, A1. Location in patent: Page/Page column 44-45
[4] Bulletin de la Societe Chimique de France, 1971, p. 1727 - 1730
[5] Archiv der Pharmazie, 1981, vol. 314, # 2, p. 156 - 162

4-CHLOROFURO[3,2-C]PYRIDINESupplier

Shanghai TBBMed Co.,Ltd Gold
Tel
021-50498136 13564881053
Email
products@tbbmed.com
Shandong utilizing biological technology co., LTD Gold
Tel
15966937598
Email
3407650895@qq.com
Accela ChemBio Co.,Ltd. Gold
Tel
021-50795510 4000665055
Email
sales@accelachem.com
J & K SCIENTIFIC LTD.
Tel
18210857532; 18210857532
Email
jkinfo@jkchemical.com
Beijing Ouhe Technology Co., Ltd
Tel
010-010-82967028 13522913783
Email
2355560935@qq.com